EUVIMEDEUVIMED entdecken
Crossref

Identifying transcriptomic predictors of brodalumab response in psoriasis using CART analysis

Vikram R Shaw, Jay Patel, Vamsi Varra

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04158-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Vikram R Shaw und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Psoriasis, Antibodies, Monoclonal, Humanized, Transcriptome, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision medicine is a topic of growing interest in psoriasis. Many novel biologics are now available to clinicians and identifying who will be a responder or non-responder to a given biologic prior to treatment is an exciting area of inquiry with strong potential clinical utility. In the present study, we use an interpretable classification and regression tree (CART) model to predict week 12 PASI75 and PASI90 response to brodalumab treatment based on clinical variables and transcriptomic data from lesional biopsy tissue samples. We identify KRT16 normalized RNA expression levels and BMI as pre-treatment predictors of a PASI75 response and FERMT1, HLA_DQA1, TMPRSS11D, and S100P normalized RNA expression levels as pre-treatment predictors of a PASI90 response. The CART models demonstrated strong AUC values for the PASI75 (0.90) and PASI90 (0.88) analyses. Taken together, focused transcriptomics has the potential to be used clinically for the pre-treatment prediction of treatment response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisAntibodies, Monoclonal, HumanizedTranscriptomeDermatologic AgentsHumansTreatment OutcomeMaleFemaleAdultMiddle AgedSeverity of Illness IndexGene Expression ProfilingPrecision MedicineBiopsy

Stichwörter der Autor:innen

BiologicOmicsPrecision medicinePsoriasis

Substanzen

brodalumabAntibodies, Monoclonal, HumanizedDermatologic Agents

Autor:innen und Institutionen

  • School of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Department of Dermatology, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Department of Dermatology, Baylor College of Medicine, Houston, TX, 77030, USA. vamsi.varra@bcm.edu.

Zitieren

APA

Shaw, V. R., Patel, J., & Varra, V. (2025). Identifying transcriptomic predictors of brodalumab response in psoriasis using CART analysis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04158-2

Vancouver

Shaw VR, Patel J, Varra V. Identifying transcriptomic predictors of brodalumab response in psoriasis using CART analysis. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04158-2

BibTeX
@article{Shaw2025,
  author = {Shaw, Vikram R and Patel, Jay and Varra, Vamsi},
  title = {Identifying transcriptomic predictors of brodalumab response in psoriasis using CART analysis},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04158-2}
}
Kostenlos starten →